Nukkleus (NASDAQ:DFNS) Cut to Strong Sell at Wall Street Zen

Wall Street Zen downgraded shares of Nukkleus (NASDAQ:DFNSFree Report) from a sell rating to a strong sell rating in a report released on Saturday,Wall Street Zen reports.

Several other equities research analysts have also recently weighed in on DFNS. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a research note on Monday, June 29th. Weiss Ratings lowered Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

View Our Latest Research Report on DFNS

Nukkleus Price Performance

DFNS stock opened at $10.24 on Friday. The company has a quick ratio of 0.11, a current ratio of 0.14 and a debt-to-equity ratio of 0.07. Nukkleus has a 12 month low of $3.70 and a 12 month high of $1,948.75. The firm has a market cap of $17.00 million, a P/E ratio of -0.03 and a beta of -5.88. The company’s 50-day moving average price is $22.08 and its two-hundred day moving average price is $69.82.

Nukkleus (NASDAQ:DFNSGet Free Report) last issued its quarterly earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.11) by ($170.69). The firm had revenue of $4.00 million for the quarter, compared to the consensus estimate of $4.50 million. On average, analysts anticipate that Nukkleus will post -3.9 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nukkleus

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets bought a new stake in shares of Nukkleus during the second quarter worth $56,000. Price T Rowe Associates Inc. MD bought a new position in shares of Nukkleus in the 4th quarter valued at $57,000. GM Advisory Group LLC acquired a new stake in shares of Nukkleus during the 4th quarter valued at $56,000. Millennium Management LLC bought a new stake in Nukkleus during the 4th quarter worth $60,000. Finally, Ausdal Financial Partners Inc. bought a new stake in Nukkleus during the 3rd quarter worth $105,000. Institutional investors own 12.47% of the company’s stock.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Read More

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.